The Use of Alendronate Is Associated with a Decreased Incidence of Type 2 Diabetes Mellitus—A Population-Based Cohort Study in Taiwan

Effect of raloxifene hydrochloride on bone mineral density and bone turnover in Kuwaiti postmenopausal women with osteoporosis

(2014) Ibrahim A. Abdelazim et al.   Archives of Osteoporosis

Risk of incident diabetes among patients treated with statins: population based study

(2013) A. A. Carter et al.   BMJ-British Medical Journal

Bone, sweet bone—osteoporotic fractures in diabetes mellitus

(2012) Christine Hamann et al.   Nature Reviews Endocrinology

Risk of Newly Diagnosed Type 2 Diabetes Is Reduced in Users of Alendronate

(2011) Peter Vestergaard   CALCIFIED TISSUE INTERNATIONAL

Change in Undercarboxylated Osteocalcin Is Associated with Changes in Body Weight, Fat Mass, and Adiponectin: Parathyroid Hormone (1-84) or Alendronate Therapy in Postmenopausal Women with Osteoporosis (the PaTH Study)

(2011) Anne L. Schafer et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effect of phylloquinone supplementation on glucose homeostasis in humans

(2010) Rajiv Kumar et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Insulin Signaling in Osteoblasts Integrates Bone Remodeling and Energy Metabolism

(2010) Mathieu Ferron et al.   CELL

Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999-2004: a national health insurance data set study

(2010) C. H. Chang et al.   DIABETIC MEDICINE

Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels

(2010) Bu B Yeap et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Effect of Vitamin K Supplementation on Insulin Resistance in Older Men and Women

(2008) M. Yoshida et al.   DIABETES CARE

Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women

(2008) Makoto Hirao et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Association between Serum Osteocalcin and Markers of Metabolic Phenotype

(2008) Anastassios G. Pittas et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Changes in bone markers after once-weekly low-dose alendronate in postmenopausal women with moderate bone loss

(2008) Hee-Jeong Choi et al.   MATURITAS